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Abstract
Postsynaptic molecules with PDZ domains (PDZ proteins) interact with various glutamate receptors and regulate their subcellular
trafficking and stability. In rat neocortical development, the protein expression of AMPA-type glutamate receptor GluR1 lagged behind its
mRNA expression and rather paralleled an increase in PDZ protein levels. One of the neurotrophins, brain-derived neurotrophic factor
(BDNF), appeared to contribute to this process, regulating the PDZ protein expression. In neocortical cultures, BDNF treatment upregulated
SAP97, GRIP1, and Pick1 PDZ proteins. Conversely, BDNF gene targeting downregulated these same PDZ molecules. The BDNF-
triggered increases in PDZ proteins resulted in the elevation of their total association with the AMPA receptors GluR1 and GluR2/3, which
led to the increase in AMPA receptor proteins. When Sindbis viruses carrying GluR1 or GluR2 C-terminal decoys disrupted their
interactions, GluR2 C-terminal decoys inhibited both BDNF-triggered GluR1 and GluR2/3 increases, whereas GluR1 C-terminal decoys
blocked only the BDNF-triggered GluR1 increase. In agreement, coexpression of SAP97 and GluR1 in nonneuronal HEK293 cells increased
both proteins compared with their single transfection, implying mutual stabilization. This work reveals a novel function of BDNF in
postsynaptic development by regulating the PDZ protein expression.
© 2003 Elsevier Inc. All rights reserved.
Keywords: BDNF; GluR1; GluR2; GRIP1; Neurotrophin; Postsynaptic density; SAP97
Introduction
Neurotrophic factors and cytokines regulate neuronal
differentiation and synaptic maturation/plasticity during
brain development (for review, see Thoenen, 2000; Poo,
2001). Such factors, including brain-derived neurotrophic
factor (BDNF), have been classified into retrograde factors,
and their functions in presynaptic neurons or terminals have
been studied extensively. The latest studies, however, dem-
onstrate that BDNF is also released from nerve terminals
and acts on postsynaptic neurons (Griesbeck et al., 1999;
Kohara et al., 2001). Accordingly, BDNF also contributes to
the morphologic and neurochemical development of the
postsynaptic compartment. For instance, it enhances the
dendritic growth of hippocampal neurons (McAllister et al.,
1997) and increases nitric oxide synthase (Xiong et al.,
1999), calbindin-D (Mizuno et al., 1994; Marty et al., 1996),
glutamic acid decarboxylase (Hyman et al., 1994; Mizuno et
al., 1994), AMPA receptor levels (Narisawa-Saito et al.,
1999), and Homer mRNA (Sato et al., 2001). This argument
is further supported by the presence of neurotrophic factor
receptors on the dendritic processes or in the postsynaptic
compartment (Aoki et al., 2000; Yacoubian and Lo, 2000).
These findings suggest the importance of neurotrophic fac-
tors in both structural and phenotypic development of
* Corresponding author. Fax: 81-25-227-0815.
E-mail address: hnawa@bri.niigata-u.ac.jp (H. Nawa).
1 Present address: Department of Molecular and Experimental Medi-
cine, The Scripps Research Institute, La Jolla, CA 92037, USA.
R
Available online at www.sciencedirect.com
Developmental Biology 263 (2003) 216–230 www.elsevier.com/locate/ydbio
0012-1606/$ – see front matter © 2003 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2003.07.008
postsynaptic neurons. In agreement, BDNF influences on
synaptic AMPA receptor sensitivity have also been docu-
mented by using the chronic BDNF application into culture
(Rutherford et al., 1998; Sherwood and Lo, 1999; McLean-
Bolton et al., 2000). However, the molecular nature of the
BDNF activity on developing postsynaptic sites has not
been fully understood. For example, the BDNF-dependent
AMPA receptor increase is not regulated at the mRNA level
but presumably at posttranslational levels (Narisawa-Saito
et al., 1999a, 1999b).
Postsynaptic density (PSD) proteins, such as PSD-95,
SAP97, and GRIP1, are a group of scaffolding molecules
that use their PDZ domains to interact with distinct gluta-
mate receptors and voltage-gated ion-channels as well as
with various signaling molecules in neurons (for review, see
Fanning and Anderson, 1999). The PDZ domain is a stretch
of 80–90 amino acids initially identified in three proteins
(PSD-95, Dlg, and ZO-1). They participate in the clustering
of glutamate receptors or in their movement into and out of
the synaptic membrane. As such, the interaction of the
AMPA receptor subunits with specific PDZ proteins is im-
plicated in various forms of synaptic plasticity. The expres-
sion of several PDZ proteins is first detected in embryonic
stages, however, and is upregulated when immature neurons
undergo synaptogenesis (Bruckner et al., 1999; Dong et al.,
1999). The regulation of PDZ proteins during development
and whether such regulation leads to the induction/matura-
tion of the synaptic compartments, including AMPA recep-
tors, remain to be determined.
Here, we found that the developmental regulation of
AMPA receptor protein is distinct from that of its mRNA in
rat neocortex. Is BDNF involved in this developmental
process by regulating the expression of their interacting
scaffolding proteins? Using neocortical cultures and a het-
erologous transient expression system in HEK293 cells, we
tested the two possibilities: (1) Exogenous or endogenous
BDNF influences the expression of PDZ proteins and (2) the
increase in PDZ proteins leads to the stabilization of AMPA
receptors through their mutual interactions. The potential
contribution of BDNF activity to synaptic development and
plasticity is also discussed.
Materials and methods
BDNF knockout mice and neocortical neuronal culture
Total protein was obtained from neocortices of six new-
born wild-type mice and from six BDNF homozygous
mutant littermates with a C57BL/6 background (Jackson
Laboratory, Bar Harbor, Maine) and was used for immuno-
blotting as indicated below. For neuronal cultures, pregnant
Sprague-Dawley rats were purchased from SLC Ltd. (Ja-
pan) and cerebral neocortices of day (d) 18 embryos were
dissociated with papain (1 mg/ml) and plated onto poly-D-
lysine-coated dishes at a cell density (500–800 cells/mm2).
Cortical neurons were grown with serum-free Dulbecco’s
modified Eagle medium (DMEM) containing nutrient mix-
ture N2 (Narisawa-Saito et al., 1999a). This procedure re-
duced glial contamination to less than 5% of total cells
(Narisawa-Saito et al., 1999a). Untreated control cultures or
cultures that were supplemented daily with purified human
recombinant BDNF (50 ng/ml; gift from Sumitomo Chem-
ical Ltd., Tokyo, Japan) for 5 d were used for all the
experiments (see below). Alternatively, long-term cortical
culture containing a lower density of cells (100–200 cells/
mm2) was maintained in N2-DMEM medium plus 5% calf
serum.
RNA analysis
Total RNA was extracted from Sprague-Dawley rats
(SLC, Shizuoka, Japan). PolyA  RNA were purified and
denatured in 50% formamide, 6% formaldehyde, 20 mM
3-(N-morpholino) propanesulfonic acid buffer (pH 7.0), and
1 mM EDTA, separated on a 1.5% formaldehyde-agarose
gel, and transferred onto a nylon membrane. A 32P-labeled
cDNA probe to rat GluR1 (a 2666-nt EcoRI–EcoRI frag-
ment), mouse GluR2 mRNA (a 699-nt ApaI–HindIII frag-
ment), rat SAP97 (a 1915-nt AccI–SpeI fragment) rat
PSD95 (a 2730-nt PCR product for the entire cording re-
gion), or rat GRIP1 (a 2511-nt PCR product for the entire
cording region) was generated by using the Random-primed
DNA labeling kit (Roche Diagnostics, Tokyo, Japan). The
probe (2  106 cpm/ml) was hybridized to filters for 20 h at
42°C in 50% formamide, 5 SSC, 5 Denhardt’s solution,
and 1% SDS followed by washing with 0.1 SSC, 0.1%
SDS at 60°C and film exposure.
Reverse transcriptase–polymerase chain reaction
(RT-PCR)
Using an RT-PCR High kit (Toyobo), cDNA fragments
for SAP97, GRIP1, Pick1, and -Actin were synthesized
from total RNA and amplified within the following linear
range amplification. The oligonucleotide primers were de-
signed as follows: 5-CTCAGAAGTTCCATAGAGCG-3
and 5-GCTTCTGTGGGCTTTATTGG-3 generating a
407-bp fragment for SAP97 (30 cycles); 5-ACCATGT-
GAAAATTCAGAGG-3 and 5-ATTCCAAAGCCAGT-
GACAGG-3 generating a 415-bp fragment for GRIP1 (28
cycles); 5-TGAGAAGTTCGGCATTCGGC-3 and 5-
GCACACACCACTCTAGCCTA-3 generating a 461-bp
fragment for Pick1 (28 cycles); and 5-CACAGCTGAG-
AGGGAAATCG-3 and 5-CACACAGAGTACTTGCG-
CTC-3 generating a 348-bp product for -Actin (24 cy-
cles). The PCR products were electrophoresed through a 2%
agarose gel, stained with a sensitive DNA dye, SyberGreen
I (Molecular Probes), and imaged with a CCD camera
(Cosmicar; Pentax).
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Immunoprecipitation and immunoblotting
Cultured neurons or rat neocortical tissues were lysed
with sample buffer [10% glycerol, 2% sodium dodecyl
sulfate (SDS), 65 mM Tris–HCl, pH 7.5]. Alternatively,
cultured neurons were lysed with immunoprecipitation
buffer (10 mM Tris–HCl, 140 mM NaCl, 1 mM EDTA, and
1% deoxycholate, pH 7.5) supplemented with protease and
phosphatase inhibitors (Wyszynski et al., 1999). Typically,
10–20 g of anti-N-terminal GluR1 (Ibaraki et al., 1999),
anti-N-terminal GluR2 (Chemicon), or anti-Pick1 (Iwakura
et al., 2001) antibodies, which had been preadsorbed to
Protein A/Protein G–Sepharose beads, were incubated with
200–400 g of total cell lysate at 4°C overnight. Immuno-
precipitated or total cellular proteins were denatured by
boiling in 3 sample buffer containing 0.1 M dithiothreitol
for 5 min, separated by SDS-polyacrylamide gel electro-
phoresis (PAGE) with 7.5 or 10% polyacrylamide slab gels,
and blotted to nitrocellulose membranes. The membranes
were treated with primary antibodies (see below) at 4°C
overnight. Immunoreactivity was detected by using goat
anti-rabbit (DAKO, Kyoto, Japan) or goat anti-mouse (Jack-
son ImmunoResearch Laboratories) antibodies conjugated
to peroxidase (diluted 1:10000) followed by chemilumines-
cence reaction (ECL kit; Amersham) combined with film
exposure. Primary antibodies used in this study were as
follows: anti-SAP97 monoclonal (1 g/ml; StressGen; Mul-
ler et al., 1995), anti-GRIP1 (1 g/ml; Upstate Biotechnol-
ogy; Dong et al., 1999), anti-SAP102, anti-PSD-93 (both 1
g/ml; Fukuya and Watanabe, 2000), anti-Pick1 (2 g/ml;
Iwakura et al., 2001), anti-PSD95/panPDZ antibodies (3
g/ml; Transduction Laboratories; Sans et al., 2000), anti-
C-terminal GluR1 (1 g/ml; Chemicon), anti-GluR2/3 (1
g/ml; Chemicon), and anti--Actin (1 g/ml; Boehringer
Mannheim) antibodies. The specificity of the immunoreac-
tivity was determined by comparing their sizes with those of
the reported molecular weights.
Culture immunostaining
Cultured neurons were washed with phosphate-buffered
saline and fixed for 20 min with 4% paraformaldehyde in
0.1 M phosphate buffer (pH 7.3). Neurons were immuno-
stained with anti-SAP97 antibody (30 g/ml; StressGen),
anti-GRIP1 (10 g/ml; Upstate Biotechnology), or anti-
PSD95/panPDZ (5 g/ml; Transduction Laboratories). Im-
munoreactivity was revealed by using the ABC-diamino-
benzidine method (Vector) and visualized with the aid of a
microscope (Axioskop; Carl Zeiss) fitted with an LCD color
camera (DP50-CU; Olympus). All pictures were taken with
a 20 objective, at 1/300 s shutter speed using Studio Lite
software (Pixera Corp.).
Cultures maintained for 2 weeks were immunostained
with anti-PSD95/panPDZ monoclonal antibody (5 g/ml;
Transduction Laboratories), the same rabbit anti-SAP97 an-
tibody, anti-synaptophysin monoclonal (20 g/ml; Sigma),
and anti-synaptobrevin monoclonal (10 g/ml; Wako
Chemical) antibodies. Immunoreactivity was revealed by
using anti-mouse immunoglobulin conjugated to Alexa 546
(red; Molecular Probes) and anti-rabbit immunoglobulin
conjugated to Alexa 488 (green; Molecular Probes).
Lipofection into HEK293 cells
Full-length cDNAs for rat GluR1, rat GluR2 (Boulter et
al., 1990), or rat GRIP1 (Dong et al., 1999) were subcloned
into pCI mammalian expression vectors (Invitrogen) and
introduced into HEK293 cells. A pCMV vector carrying the
cDNA for rat SAP97 (Muller et al., 1995) was used for
transfection as well (gift from Drs. Y. Hata and Y. Takai).
HEK293 cells were plated onto plastic dishes (10 cm diam-
eter) at a density of 500–1000 cell/mm2 24 h prior to their
transfection. Transfection of these plasmid constructs was
performed by lipofection with FuGENE 6 (Roche).
Infection of Sindbis virus vector carrying GluR1- and
GluR2-carboxyl terminal decoys
The modified enhanced green fluorescent protein (EGFP)
that carried either the carboxyl terminal sequence of GluR1
(SSGMPLGATGL; Leonard et al., 1998) or that of the short
C-terminal isoform of GluR2 (GYNVYGIESVKI; Kohler et
al., 1994) was constructed as described previously (Iwakura
et al., 2001). Viral genome RNAs were transcribed in vitro
by SP6 RNA polymerase using the Invitroscript CAP kit
(Invitrogen) and cotransfected with mRNAs coding viral
coat proteins into baby hamster kidney (BHK) cells. The
infectivity of the Sindbis virus particles was titered with
BHK cells by serial dilution. Typically, a viral titer of
greater than 107 pfu/ml was obtained.
Cultured neocortical neurons were exposed to the Sind-
bis viral vectors at a titer of greater than 107 pfu/ml for 1 h.
After washing, the neurons were incubated in regular
growth medium at 37°C for 24 h in the presence or absence
of BDNF. The expression of EGFP was monitored with the
aid of a fluorescence microscope. At the viral titer used for
infection, more than 90% of neurons expressed green fluo-
rescence (Iwakura et al., 2001). The BDNF effects on PDZ
proteins and AMPA receptors were determined by immu-
noprecipitation and immunoblotting as described above.
Statistical analysis
The Student’s t-test was used to analyze differences in
immunoreactivity when the number of samples per set in-
cluded more than three. Alternatively, the set of control and
experimental group(s) covered multiple independent exper-
iments done at distinct periods of time, comparisons be-
tween BDNF-treated or control groups were made with the
Mann-Whitney U-test. A single developmental curve of
mRNA expression was compared with the standard distri-
bution of the data set of protein expression. Results were
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expressed as means  standard deviation (SD), and the
number of similar experiments is indicated in each figure
legend.
Results
Developmental regulation of PDZ proteins and their
associating AMPA receptor subunits
Among many PDZ proteins, SAP97 specifically interacts
with the C-terminal tail of GluR1 (Leonard et al., 1998),
whereas GRIP1, GRIP2/ABP, and Pick1 bind to the tails of
GluR2/3 subunits (Kohler et al., 1994; Srivastava et al.,
1998; Dev et al., 1999; Dong et al., 1999; Wyszynski et al.,
1999; Xia et al., 1999). On the other hand, SAP102, PSD-
95, and PSD-93/Chapsin-110 associate with the NMDA
receptor subunits (Kornau et al., 1995; Lau et al., 1996;
Muller et al., 1996). How do their interactions influence
their expression, stability, and functions during brain devel-
opment?
In developing rat neocortex, we determined the protein
expression of AMPA receptor subunits, GluR1 and
GluR2/3, and their partner PDZ proteins, SAP97, GRIP1,
and PSD95/panPDZ to compare with their regulation at the
mRNA level (Fig. 1). Immunoblotting revealed that most of
these postsynaptic proteins were expressed from late em-
bryonic stages, before synaptic formation or maturation.
Protein levels for GluR1 and GluR2/3 were first detected at
E16-E18, when neurons underwent the final mitosis and
migrated to the cortical plate, and gradually increased when
cortical neurons actively form many synapses until P20-
P30. A similar prenatal and postnatal developmental in-
crease was seen in these PDZ proteins. The antibody di-
rected against PSD-95 recognized homologous PDZ
proteins (also referred to as panPDZ antibody). GRIP1 pro-
tein and PSD95/panPDZ-like immunoreactivity were de-
tectable as early as E14 in rat cortex. The developmental
patterns of their mRNA expressions were determined by
RNA blotting to compare with those of the proteins (Fig.
2A). GluR1 and GluR2 mRNAs exhibited a relatively sharp
increase around birth (P0). The developmental increase in
GluR1 mRNA significantly preceded that in GluR1 protein,
whereas the developmental change in GluR2 mRNA par-
tially disagreed but almost paralleled with that in GluR2/3
protein (Fig. 2B). Similar to GluR1 mRNA, mRNA levels
for GRIP1 and PSD95 markedly increased between E14 and
E19 or between E19 and P7, and gradually decreased in the
later stages of development. The apparent discordance be-
tween mRNA and protein levels suggest that the develop-
mental regulation of the postsynaptic proteins may also
involve a posttranscriptional regulatory mechanisms such as
synaptic stabilization.
BDNF increases the expression of AMPA receptor-
associated PDZ proteins
Cultured neocortical neurons were prepared from embry-
onic day 18 rats and grown in a serum-free condition for 5
days in the presence or absence of BDNF to examine its
influences on PDZ proteins and their mRNAs (Fig. 3). The
presence of BDNF made no difference in cell densities in
insulin-enriched serum-free culture as reported previously
(see details in Fig. 5 legend) (Narisawa-Saito et al., 1999a).
Immunoblotting of culture lysates revealed that BDNF sig-
nificantly enhanced the expression of SAP97, GRIP1, and
Pick1 in cortical neurons. In addition, the intensity of bands
immunoreactive for the anti-PSD95/panPDZ antibody (83-
110 kDa), which recognizes PSD-95 and crossreacts with
common PDZ domains, was increased by chronic BDNF
stimulation. BDNF effects on PDZ proteins were not
blocked by glutamate receptor antagonists (CNQX, AP-5;
data not shown). In contrast, BDNF had no effects on
SAP102 and PSD-93. Protein levels for -actin were not
influenced, either. The ineffectiveness of BDNF on SAP102
and PSD-93 suggests that the above BDNF activity did not
represent a general neurotrophic function on neurons and
synaptic molecules. Quantification of mRNA had slightly
different results, however: The effects of BDNF at the PDZ
protein level were reflected by an increase in GRIP1 and
Pick1 mRNAs but not by that of SAP97. BDNF had no
effects on -actin mRNA. Consistent results were obtained
when the amounts of RT-PCR products were normalized
with an internal control of -actin mRNA (data not shown).
These observations suggest that BDNF specifically en-
Fig. 1. Developmental regulation of AMPA receptor subunits and PDZ
proteins. Relative protein levels for GluR1, GluR2/3, GRIP1, SAP97, and
PSD95 (panPDZ) were determined in rat neocortex by immunoblotting.
Rat cerebral cortex was isolated from rats at various ages and total protein
was extracted. Protein (40 g) was separated on a 7.5% SDS-PAGE and
blotted onto a nitrocellulose membrane. Lanes correspond to embryonic
days (E16 and E18) and postnatal days (P0, P5, P10, P20, P30, and P60).
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hances the protein expression of the AMPA receptor-asso-
ciated PDZ molecules, SAP97, GRIP1, and Pick1, although
the mechanism underlying the BDNF regulation of GRIP1
and Pick1 is apparently different from that affecting SAP97.
The BDNF knockout mice were used to validate the in
vitro effects of BDNF on PDZ proteins in vivo. Total
protein was extracted from the neocortex of the homozy-
gous mutants and control mice on postnatal day 1 and
subjected to immunoblotting for SAP97, GRIP1, and Pick1
(Fig. 4). BDNF gene disruption reduced the levels of
SAP97, GRIP1, and Pick1 proteins in the neocortex. In
contrast, -actin protein levels were not affected by the
absence of BDNF. These observations suggest that the neu-
rotrophin regulates the expression of this particular set of
PDZ proteins during development.
Enhanced immunoreactivity for the PDZ proteins in
BDNF-treated neocortical culture
Immunostaining of cultured neurons confirmed the ef-
fects of BDNF on SAP97 and GRIP1 proteins, as well as on
PDZ proteins reactive to the anti-PSD95/panPDZ antibody
(Fig. 5). BDNF-treated cultures had enhanced SAP97-like
and GRIP1-like immunoreactivities, compared with con-
trols (Fig. 5A and D, and B and E, respectively). Immuno-
reactivity to the anti-PSD95/panPDZ antibody had a
similar BDNF-dependent intensification (Fig. 5C and F)
and reflected the increase detected with immunoblotting.
The neuronal populations immunoreactive to each indi-
vidual antibody seem to have different cell morpholo-
gies, despite some overlap. For instance, the anti-SAP97
and anti-PSD95/panPDZ antibodies stained a hetero-
geneous cell population with a predominance of large cells
(mean longer axis; 14  2.3 m). Conversely, the vast
majority of cells with strong immunoreactivity to the
anti-GRIP1 antibody were smaller (mean longer axis; 8.5
2.1 m).
The effects of BDNF on the expression of PDZ proteins
in neocortical cultures having more developed synapses
were evaluated as well (Fig. 6). The neocortical cultures
were maintained for 2 weeks in the presence or absence of
BDNF. The expression of PDZ proteins was assessed by
using the anti-SAP97 antibody as well as the anti-PSD95/
panPDZ antibody. BDNF treatment influenced the PSD95/
panPDZ immunoreactivity along the dendrites. Punctate
staining for the PSD95/panPDZ antibody was more frequent
and stronger along the dendrites of BDNF-treated neurons.
The number of strong PSD95/PDZ-positive spots was 730
 140 spots/mm dendrite in the BDNF-treated culture and
60  8 spots/mm dendrite in control, respectively (P 
0.001). In contrast, there was no apparent difference in
SAP97 immunoreactivity in this long-term cortical culture.
The number of presynaptic sites that were marked with
anti-synaptobrevin and anti-synaptophysin monoclonal an-
tibodies was similar between the cultures (see Fig. 6 leg-
Fig. 2. mRNA expression of AMPA receptors and PDZ proteins during rat
neocortical development. (A) Brain mRNA levels for GluR1, GluR2,
GRIP1, and PSD95 were examined during rat development by RNA
blotting. Rat cerebral cortex was isolated from rats at various ages, and
total RNA was extracted. PolyA RNA (1.8 g) was separated on a 1.5%
formamide agarose gel and blotted onto a nylon membrane. Lanes corre-
spond to embryonic days (E14 and E19), postnatal days (P0, P7, and P14),
and postnatal months (M1 and M6) from left to right. (B) mRNA levels for
GluR1 and GluR2 were determined by densitometric analysis of the blots
and compared with their protein levels. The protein levels were similarly
measured by three independent immunoblots as shown in Fig. 1. *P 
0.05, out of 2 SD range.
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end). This result indicates that the BDNF activity might
have different time windows to regulate the individual
AMPA receptor-associated PDZ proteins.
BDNF elevates the amounts of SAP97 and GRIP1
associating with AMPA receptor subunits
The BDNF-enhanced PDZ proteins, SAP97, GRIP1, and
Pick1, were identical to those that are known to interact with
the AMPA receptor subunits (Leonard et al., 1998; Dev et
al., 1999; Dong et al., 1999; Iwakura et al., 2001). Does the
BDNF-triggered increase in the PDZ proteins influence
their association with the AMPA receptors and stabilize the
AMPA receptor expression? To study the secondary effects
of BDNF on AMPA receptors via PDZ proteins, culture
lysates were subjected to immunoprecipitation to examine
the interaction between GluR1 and SAP97, GluR2/3 and
GRIP1, or Pick1 and GluR2/3 (Fig. 7). BDNF elevated the
interaction between GluR1 and SAP97 as well as between
GluR2 and GRIP1. In contrast, Pick1 association with
GluR2/3 was not altered by chronic incubation of the neu-
rons with BDNF, even though the incubation did indeed
upregulate Pick 1 expression. Thus, chronic BDNF treat-
ment also elevated total amounts of the interaction of
Fig. 3. BDNF differentially regulates the expression of various PDZ pro-
teins. Neocortical neurons were cultured in serum-free medium in the
presence or absence of BDNF (50 ng/ml) for 5 days. Total cellular protein
was collected and processed for immunoblotting. (A) Typical examples of
immunoblotting are displayed. (B) The blotting results of similar culture
experiments (four cultures and blots with duplicated lanes; total n  8)
were quantified by densitometry and plotted. (C) cDNA bands amplified by
RT-PCR for the indicated molecules showed that BDNF chronic applica-
tion resulted in increased signals for GRIP1 and Pick1. The same treatment
did not modify SAP97 nor -Actin mRNAs. “” represents PCR reaction
without mRNA as a negative control. mRNA was derived from two
independent cultures. **P  0.005 with the Mann-Whitney U-test.
Fig. 4. Impaired expression of PDZ proteins in the neocortex of BDNF-
gene knockout mice. On postnatal day 1 the neocortex was dissected from
homozygous BDNF knockout mice and from wild-type littermates. SAP97,
GRIP1, and Pick1 protein levels were analyzed by immunoblotting. (A)
The expression of -actin was not affected by the lack of BDNF. (B) Total
levels of PDZ proteins were quantified by densitometry and compared in
the wild type and BDNF-homozygous mutant mice (n  6 mice, each). *P
 0.05; **P  0.005 with the Mann-Whitney U-test.
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SAP97 and GRIP1 with the AMPA receptors. The speci-
ficity of the combination having the enhanced interactions
implies that the increase in total amounts of these two
classes of molecules may not simply result in their mutual
interaction, however. Accordingly, we cannot rule out the
possibility that BDNF might enhance the affinity of their
interaction as well.
Disruption of GluR1 and GluR2 interactions with their
partner PDZ proteins is detrimental to the BDNF-
dependent increase in the AMPA receptors
Sindbis viruses carrying the cDNA of EGFP alone or that
of EGFP attached to either the C-terminal decoy of GluR1
(11 amino acids; EGFP-R1) or that of the short isoform of
GluR2 (12 amino acids; EGFP-R2) (Kohler et al., 1994)
were used to perturb the endogenous interactions between
the AMPA receptor subunits and the PDZ proteins (Iwakura
et al., 2001). These C-terminal decoys code for the amino
acid sequences that are involved in the interaction of GluR1
with SAP97 (Leonard et al., 1998) or GluR2 with GRIP1
(Dev et al., 1999; Dong et al., 1999) and Pick1 (Iwakura et
al., 2001). The interaction with these PDZ proteins is im-
plicated in trafficking and stability of AMPA receptors
(Kohler et al., 1994; Srivastava et al., 1998; Dev et al.,
1999; Dong et al., 1999; Wyszynski et al., 1999; Xia et al.,
1999). Therefore, disruption of such interactions might clar-
ify the role of BDNF on the increase in AMPA receptor
proteins.
The viral transcripts carrying these decoys were synthe-
sized in vitro by T4 RNA polymerase and transfected into
cultured neocortical neurons (Fig. 8A and B). The individ-
ual expression of native GluR1 and GluR2/3 proteins was
examined by immunoblotting (Fig. 8C and D, respectively).
Infecting neocortical cultures with the control EGFP vector
alone did not inhibit the BDNF-dependent increase in
GluR1 and GluR2/3 proteins (Fig. 8E and F). Infection with
the EGFP-R1 virus and the resultant overexpression of the
GluR1 C-terminal decoy counteracted the BDNF-mediated
increase in native GluR1 (Fig. 8E), while the BDNF-depen-
dent increase was still detectable in GluR2/3 (Fig. 8F).
Similarly, EGFP-R2 infection led to its overexpression but
decreased the basal expression of GluR2/3 protein (Fig. 8F).
It also blocked the BDNF-dependent increase in GluR2/3.
In agreement with the results from both decoys, they indeed
diminished the interactions between GluR1 and SAP97 and
between GluR2/3 and GRIP1 in the presence of BDNF (Fig.
8G). Interestingly, EGFP-R2 decoy expression appeared to
counteract the BDNF-triggered increase in native GluR1 as
well (Fig. 8C and E). These results indicate that the com-
peting decoys were sufficient to reverse the BDNF-medi-
ated increase in GluR1 and GluR2, although the influence of
each AMPA receptor decoy differed slightly on each sub-
unit, presumably because it depends on the subunit compo-
sition of the AMPA receptor complexes in the infected
neocortical neurons (Kondo et al., 1997). These findings
support the hypothesis that the BDNF-triggered total protein
increase in AMPA receptors involves their molecular inter-
action via their carboxyl termini with PDZ proteins.
Coexpression of GluR1 and SAP97 elevates their protein
levels in HEK293 cells
The previous lines of evidence suggest that BDNF in-
creases the expression of AMPA receptor-associated PDZ
proteins and then elevates the amount of their mutual inter-
action leading to receptor protein stabilization (Narisawa-
Saito et al., 1999a,b). To confirm the significance of these
interactions, we established a heterologous experimental
system in the human kidney cell line, HEK293: cDNA for
GluR1 or the short C-terminal isoform of GluR2 (Kohler et
al., 1994) alone, or together with that of SAP97 or GRIP1
was transduced by lipofection and all were transiently ex-
pressed under the cytomegalovirus promoter (Fig. 9). Fol-
lowing the transient transfection, the magnitudes of their
protein levels were examined by immunoblotting. Cotrans-
fection of GluR1/SAP97 or GluR2/GRIP1 was compared
with the single transfection of GluR1 or GluR2.
The cotransfection of GluR1 cDNA and SAP97 cDNA
markedly enhanced GluR1 protein levels in comparison
with those obtained with GluR1 cDNA transfection alone
(Fig. 9A), and this increase was detected over the period of
3 days following transfection. Protein expression of SAP97
itself was also enhanced in the presence of GluR1. In con-
trast, the cotransfection of GluR2 cDNA and GRIP1 cDNA
over the same period of time promoted neither the protein
expression of GluR2 nor that of GRIP1 (Fig. 9B). The
molecular behaviors of the AMPA receptors in the nonneu-
ronal cells suggest that the presence and interaction of
SAP97 facilitate the expression of the AMPA receptor sub-
unit.
Discussion
Developmental regulation of PDZ protein expression
Postsynaptic density proteins with PDZ domains have
been intensively studied in the context of synaptic plasticity
in mature brain. However, some PDZ proteins are expressed
Fig. 5. BDNF enhanced PDZ protein immunoreactivity in cultured neocortical neurons. Control (A–C) or BDNF-treated (D–F) neocortical neurons in culture
were fixed and incubated with anti-SAP97 antibody (A, D), anti-GRIP1 antibody (B, E), or anti-PSD95/panPDZ antibody (C, F). Immunoreactivity was
visualized with the DAB-peroxidase technique. Chronic incubation with BDNF (50 ng/ml daily for 5 days) significantly enhanced the staining with the three
antibodies. Cell density was 3500  400 cells/mm2 in control culture and 3100  300 cells/mm2 in BDNF-treated culture. Scale bar, 30 m.
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in immature embryonic neurons (Dong et al., 1999; Osten et
al., 2000) and some interact with cell adhesion molecules,
such as neuroligins (Irie et al., 1997), vascular cell adhesion
molecule, and neuron-specific synaptic scaffolding mole-
cule (Ide et al., 1998). Moreover, recent studies indicate a
role for PDZ proteins in the regulation of neuronal differ-
entiation and synaptic development (El-Husseini et al.,
2000; Penzes et al., 2001). In contrast to a large variety of
molecular investigations on PDZ proteins, information on
their developmental contribution is still limited. In the
present study, the expression of several PDZ proteins begins
during the embryonic development of the rat neocortex.
Their binding partners, AMPA receptor proteins, display a
similar developmental pattern of their expression. The
present results reveal a novel role of BDNF in the develop-
mental regulation of these PDZ proteins as well as in that of
AMPA receptor proteins.
The developmental patterns of AMPA receptor protein
expressions partially differ from those of their mRNA lev-
els. For example, the developmental increase in GluR1
proteins markedly lagged behind that of its mRNA. The
discordance between protein and mRNA levels of the
postsynaptic proteins is also evident in previous literatures
(Durand and Zukin, 1993; Arai et al. 1997). Both exogenous
or endogenous BDNF not only upregulate the expression of
PDZ proteins but also secondarily stabilize that of AMPA
receptor subunits through their interaction with those PDZ
proteins. Thus, the above developmental discordance be-
tween their proteins and mRNAs might also be ascribed to
the secondary BDNF action through its regulation of PDZ
proteins. The BDNF effects might not be limited to the
above AMPA receptor-associating PDZ proteins but could
also include potentially unidentified ones immunoreactive
for the PSD95/panPDZ antibody (Kitano et al., 2002).
Postsynaptic effects of BDNF
BDNF has been implicated in dendritic growth as well as
in synapse formation (Causing et al., 1997; McAllister et al.,
1997; Kong et al., 2001), suggesting a potential influence on
postsynaptic proteins. Chronic BDNF effects involve vari-
ous types of intra- and intercellular molecules (Mizuno et
al., 1994; Takei et al., 1997; Narisawa-Saito et al., 1999a;
Xiong et al., 1999). The present results implicate a new
series of molecules, namely the AMPA receptor-associated
PDZ proteins, and suggest a molecular mechanism that
Fig. 6. Effects of BDNF on the immunoreactivity for PDZ proteins in mature cortical culture. Lower density neocortical cultures were grown for 2 weeks
with or without BDNF. After fixation, immunoreactivity for the anti-PSD95/panPDZ antibody was visualized with Alexa 546-conjugated secondary antibody
(red) (A). (B) Immunostaining of presynaptic structures was marked with the mixture of anti-synaptobrevin and anti-synaptophysin monoclonal antibodies
followed by the Alexa 546-conjugated secondary antibody (red). Immunostaining for SAP97 was simultaneously visualized with the Alexa 488-conjugated
secondary antibody (green). Dendritic processes were randomly pictured (n 15 each for A and B) and immunoreactive spots along dendritic processes were
counted. Densities of SAP97-positive spots and synaptophysin/synaptobrevin-positive terminals were 243.4  71.0 and 295.4  102.8 spots/mm dendrite
in the BDNF-treated culture and 289.2  114.8 and 245.2  118.6 spots/mm dendrite in control, respectively; P  0.67 for SAP97-positive spots and 0.83
for synaptophysin/synaptobrevin-positive spots. Pictures of dendrites having higher immunoreactivities were chosen for display (A; n  5 each, B; n  2
each). Scale bar, 10 m.
Fig. 7. BDNF enhanced the association of GluR1 and GluR2/3 with SAP97
and GRIP1 in neocortical neuronal cultures. Neurons were incubated, with
or without BDNF (50 ng/ml), for 5 days. Protein samples were 1%
DOC-extracted and used for coimmunoprecipitation (co-IP). Co-IP of
SAP97 with anti-N-terminal GluR1 antibody (A), GRIP1 with anti-N-
terminal GluR2 antibody (B), or GluR2/3 with anti-Pick1 antibody (C)
revealed that only SAP97-GluR1 and GRIP1-GluR2/3 interactions were
enhanced by BDNF in the treated cultures. To control the above co-IP
reaction, immunoblots were reprobed with anti C-terminal GluR1 and anti
C-terminal GluR2/3 antibodies (lower panels in A and B). Because of the
similarity in the molecular sizes of Pick1 and the immunoglobulin heavy
chain, the co-IP reaction was started with the anti-Pick1 antibody and
immunoblotting was carried out with anti-GluR2/3. In addition, total cel-
lular lysates were immunoblotted with anti-Pick1 antibody, which revealed
that Pick1 protein was enhanced by BDNF (C). Each lane represents
independent sister culture.
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Fig. 8. Overexpression of GluR1 and GluR2 C-terminal decoys disrupted the BDNF-mediated increase in AMPA receptors. Neocortical neurons were
cultured for 4 days and then incubated with () or without () BDNF for the last 24 h before harvesting. The shorter BDNF treatment was still able to mimic
a similar magnitude of the protein increase in AMPA receptors. During the incubation with BDNF, neurons were infected with the Sindbis viruses coding
for EGFP alone, EGFP-R1 (A), or for EGFP-R2 (B) (Iwakura et al., 2001) to study the consequences of disrupting AMPA receptors’ interaction with their
associated PDZ proteins. At the viral titre used ( 1  107), more than 90% of the cells were infected, as monitored by EGFP fluorescence (Iwakura et al.,
2001). The control EGFP construct was essentially the same as the EGFP-R1 and EGFP-R2 constructs but lacked the decoy peptides. (A and B) nsp,
nonstructural proteins; psg, subgenomic promoter; and poly A; poly-adenylated transcript tail. Hatched boxes fused to the EGFP represent the C-terminal
decoys of GluR1 and GluR2 (short splice variant). (C) Probing with anti-C-terminal GluR1 revealed the native GluR1 band as well as a lower band
corresponding to the expected size of EGFP-R1 fusion protein (28 kDa). (D) Similarly, the BDNF-induced increase in GluR2/3 protein was challenged by
the overexpression of EGFP-R2 fusion protein. Statistical analysis of the GluR1 (E) and GluR2/3 (F) immunoreactivities between pairs of BDNF-plus and
BDNF-minus cultures (n  3). GluR1 or GluR2/3 immunoreactivity in virus-free control culture was set as 100%. Student’s t-test was applied to comparison
between BDNF-plus and BDNF-minus cultures (*P  0.05; **P  0.01) or between the cultures transfected with EGFP-R2 and EGFP alone (P  0.05).
(G) The overexpression of EGFP-R1 and EGFP-R2 decoys reduced the BDNF-stimulated interaction between GluR1 and SAP97 and between GluR2/3 and
GRIP1, respectively, compared with that in the EGFP overexpression. Cell lysates were prepared from infected neocortical cultures and treated with
anti-N-terminal GluR1 antibody or anti-N-terminal GluR2 antibody to immunoprecipiate the complexes of AMPA receptors and PDZ protein(s).
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might underlie our previous finding: BDNF enhances the
protein expression of GluR1 and GluR2/3 without altering
their mRNA levels (Narisawa-Saito et al., 1999b). Although
BDNF is known to influence synaptic activity (Kang and
Schuman, 1995; Figurov et al., 1996; Korte et al., 1996;
Patterson et al., 1996) and neuronal translation rates (Takei
et al., 2001), both processes appeared not to contribute to
the AMPA receptor increase. First, BDNF failed to further
elevate translation rates in the present culture condition
containing high amounts of insulin (N.T., unpublished
data). Secondly, the BDNF effects on PDZ proteins were
resistant against glutamate receptor antagonists (CNQX,
AP-5; data not shown), eliminating the possibility that the
PDZ protein increase required endogenous synaptic activ-
ity. Furthermore, this explanation is also supported by two
distinct approaches, the viral perturbation experiments and
the reconstitution of the phenomenon in nonneuronal cells.
Disruption of the interaction with GluR decoys inhibited not
only the interactions between GluR1 and SAP97 and be-
tween GluR2/3 and GRIP1 but also the BDNF-triggered
AMPA receptor increases. Transient coexpression of
SAP97 together with GluR1 in HEK 293 cells resulted in
their mutual interaction in parallel with the elevation in
GluR1 protein. A similar scenario might be applicable to the
BDNF-dependent upregulation of expression of other bind-
ing partner(s) for the above PDZ molecules. Thus, impaired
learning ability of BDNF/TrkB knockout mice or BDNF/
TrkB transgenic mice might also involve developmental
deficits in these postsynaptic molecules or in such postsyn-
aptic regulation (Linnarsson et al., 1997; Croll et al., 1999;
Minichiello et al., 1999; Saarelainen et al., 2000; Xu et al.,
2000).
Carboxyl terminal domains of AMPA receptors are
important for stabilization
The perturbation experiments using Sindbis viruses car-
rying the GluR1 and GluR2 C-terminal decoys revealed the
molecular significance of these C-terminal domains in the
expression and stabilization of the AMPA receptors in neu-
rons. Disrupting their binding with Sindbis viruses carrying
the GluR1 and GluR2 C-terminal decoys inhibited the
BDNF-mediated enhancement of their individual expres-
sion.
The overexpression of GluR2 C-terminal decoys resulted
in marked reduction in basal GluR2 expression. In addition,
the coexpression of GRIP1 and the AMPA receptors failed
to stabilize the receptors in HEK293 cells, although GRIP1
binds to GluR2/3 subunits and is suggested to stabilize the
AMPA receptor subunits in a phosphorylation-independent
manner (Dong et al., 1999; Wyszynski et al., 1999; Matsuda
et al., 2000; Osten et al., 2000). The difference between the
results from cortical neurons and HEK293 cells could be
ascribed to the lack of essential component(s) for the PDZ
protein(s) or for its posttranslational modification in the
nonneuronal cells (Craven et al., 1999; Chung et al., 2000;
Fig. 9. Effects of coexpression of SAP97 and GRIP1 proteins on AMPA
receptor levels in HEK293 cells. cDNA for GluR1 or GluR2 in expression
vector plasmids carrying the CMV promoter was transfected into human
embryonic kidney cells, HEK293, together with that for SAP97 or GRIP1,
respectively. Their transient expressions were monitored on days 1, 2, and
3 by immunoblotting. cDNAs used in each experiment are indicated on top
of each blot. Three independent experiments were performed, and protein
levels for GluR1 or GluR2 were quantified by densitometry for statistical
analysis. Significant interaction between GluR1 and SAP97, or GluR2 and
GRIP1, was indeed detected in the immunoprecipiates with the anti-N-
terminal GluR1 antibody or the anti-N-terminal GluR2 antibody, respec-
tively (data not shown). Results were obtained from three sets of cultures
(n  3). *P  0.05; **P  0.005 with paired Student’s t-test.
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Daw et al., 2000). In fact, it has already been suggested that
the cellular and molecular behaviors of individual AMPA
receptor complexes are governed by a variety of PDZ pro-
teins, by their specific cellular environment, as well as by
other partner molecules (Shi et al., 2001; McLean-Bolton et
al., 2000). Apparently, BDNF could contribute to this phe-
notypic difference in the relationship between these PDZ
proteins and their interacting individual AMPA receptor
subunits. This implies the existence of distinct regulatory
mechanisms leading to unique responses to BDNF depend-
ing on the subunit composition of the complexes and the
expression of various PDZ proteins in different neuronal
populations.
The molecular interaction between the GluR1 C-terminal
motif with partner PDZ proteins, potentially with SAP97,
can lead to the translocation of the GluR1-carrying AMPA
receptor complexes to postsynaptic compartments (Hayashi
et al., 2000; Shi et al., 2001). In fact, SAP97 protein asso-
ciates with GluR1 in the intracellular biosynthetic mem-
branes during development but is distributed at the postsyn-
aptic sites in mature synapses (Valtschanoff et al., 2000;
Sans et al., 2001). Consistent with these observations, im-
munoreactivity for SAP97 was more distributed in somatic
regions rather than in dendrites in young neocortical cul-
tures. In mature culture, however, strong immunoreactivity
for SAP97 appeared as spots along the dendrites, presum-
ably marking postsynaptic sites. The ultrastructural distri-
bution of the BDNF-affected PDZ proteins needs to be
characterized at the electron microscopic level, however.
Our latest study indicates that the acute stimulation of
BDNF rapidly induces surface translocation of GluR2 sub-
unit through its interaction with N-ethylmaleimide-sensitive
factor but not with PDZ protein (Narisawa-Saito et al.,
2002). Accordingly, the chronic BDNF stimulation might
trigger both processes involving GluR1 and GluR2 to aid
the synaptic translocation and stabilization of the PDZ mol-
ecule–AMPA receptor complexes. Recently, Chetkovich et
al. (2002) found that another PDZ molecule, PSD-95, indi-
rectly interacts with GluR1 via Stargazin to translocate it to
the postsynaptic sites. In this context, we cannot deny the
possibility that PSD-95 might also contribute to the above
process, although we failed to obtain consistent effects of
BDNF on this PDZ molecule. BDNF is released from nerve
terminals and acts on postsynaptic sites (Griesbeck et al.,
1999; Kohara et al., 2001) to translocate AMPA receptors
(Narisawa-Saito et al., 2002) and enhance the expression of
their associating PDZ proteins. Accordingly, the local ac-
tion of BDNF presumably contributes to selective postsyn-
aptic development.
Differential regulation of postsynaptic differentiation
and/or maturation by neurotrophic molecules
Many neurotrophic factors and cytokines regulate neu-
ronal differentiation and development (Thoenen, 2000; Poo,
2001). The members that regulate postsynaptic structure
and/or phenotype, however, have been poorly characterized.
Neuregulins are important effectors in synaptic develop-
ment in the brain. These factors regulate synaptic expression
of alpha acetylcholine receptor subunits in the periphery and
influence the alpha 7 subunit and NMDA receptors in the
brain (Ozaki et al., 1997; Rieff et al., 1999; Liu et al., 2001).
In neuronal cultures, BDNF had a much greater effect,
compared with nerve growth factor and neurotrophin-3, on
the expression of both AMPA-type glutamate receptor sub-
units (Narisawa-Saito et al., 1999a) and PDZ proteins (un-
published data). Conversely, basic fibroblast growth factor
downregulates the expression of a different subset of PDZ
proteins (Jourdi and Nawa, 2002). All the above observa-
tions led us to presume that many neurotrophic factors and
cytokines can influence the expression of various PDZ pro-
teins during brain development and could contribute to the
activity-dependent glutamate receptor expression as well
(Gold et al., 1996). There is a distinct distribution of neu-
rotrophic factor and cytokine receptors in the brain. There-
fore, it will be interesting to elucidate whether and how
these neurotrophic molecules differentially affect PDZ pro-
teins, contributing to the divergence in individual synaptic
functions and/or their development.
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